You are here

Policy

 

The Senate will not vote on the Republican plan to repeal and replace the Affordable Care Act before the July 4 recess. Majority Leader Mitch McConnell, R-Kentucky, informed his Republican colleagues at a June 27 lunch, according to multiple news outlets.

Some 22 million more people would be uninsured by 2026, deductibles and out-of-pocket costs would sharply rise while premiums would be lower and certain markets could be unstable if the Senate’s version of an Affordable Care Act repeal-and-replace plan becomes law, according to the Congressional Budget Office.

Reaction to the Senate’s version of an Affordable Care Act repeal-and-replace plan, titled the Better Care Reconciliation Act (BCRA) ranged from strong opposition from physician and hospital groups to outrage from Democrats, while one insurance organization saw some positives in the legislation.

Groups representing physicians, hospitals, internists and health IT were quick to praise the proposed rule for the second year of the new payment tracks under the Medicare Access and CHIP Reauthorization Act (MACRA). The American Medical Group Association, however, has a decidedly different take.

The legislation takes many provisions from the House-passed American Health Care Act (AHCA) under a new name: the Better Care Reconciliation Act (BCRA).

 

Recent Headlines

AMA 2017: Delegates take aim at Trump with new policies

The American Medical Association (AMA) adopted a wide range of new policies at its annual meeting of delegates in Chicago, ranging from more practice-oriented concerns to politically-charged resolutions related to the positions of President Donald Trump.

Democrats’ bill would make reinsurance permanent for ACA exchanges

Legislation to establish a permanent reinsurance program for the Affordable Care Act marketplace has been introduced by five Democratic senators.

AHA to CMS: Suspend hospital star ratings, eCQM reporting

In a letter to CMS, the American Hospital Association (AHA) recommended the agency’s deregulation efforts begin with suspending the hospital star ratings, which it called “inaccurate and misleading.”

Trump calls House’s ACA repeal bill ‘mean’

President Donald Trump reportedly told Republican senators the House-passed version of the American Health Care Act (AHCA) is “mean” and asked for the Senate version to be “more generous,” according to congressional sources who spoke to the Associated Press.

CMS actuary: AHCA could cause individual market to collapse

A report from CMS Chief Actuary Paul Spitalnic estimated 13 million fewer people will have insurance coverage under the House-passed version of the American Health Care Act (AHCA), a markedly lower figure than the 23 million predicted by the Congressional Budget Office (CBO).

4 things to know about major medical groups’ anti-AHCA events

Eight groups representing patients, hospitals and physicians will step up efforts opposing the Republican-sponsored American Health Care Act (AHCA) by holding events in four steps to “address shortcomings” in the Affordable Care Act (ACA) replacement plan.

AMA 2017: ACA repeal dominates leaders’ speeches

In their two speeches opening the American Medical Association’s 2017 meeting in Chicago, CEO James Madara, MD, and President Andrew Gurman, MD, both focused on the efforts to repeal and replace the Affordable Care Act (ACA) with a bill the AMA has actively opposed.

AMA 2017: Medicaid changes in AHCA could limit healthcare delivery innovation

The American Medical Association (AMA) doesn’t think highly of how the Senate may change Medicaid funding and coverage through repealing and replacing the Affordable Care Act (ACA), judging by a presentation from the AMA’s annual meeting in Chicago.

What AMA delegates will vote on at 2017 meeting

The 2017 annual meeting of the American Medical Association’s House of Delegates will take place June 10-14 in Chicago, with educational sessions beginning on June 9. Like every year, delegates have a full slate of proposed resolutions—some more political than related to practice—to consider.

Q&A: Duke's Daniel on the challenges of moving pharma, device companies toward value-based payment

Finding a practical path for pharmaceutical and medical device manufacturers to enter value-based payment arrangements is the goal of a new policy consortium formed at the Robert J. Margolis, MD, Center for Health Policy at Duke University.

Pages